Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1608)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Correspondence (23)
  9. Conference Paper (22)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1694)
  2. Survivorship Research (1196)
  3. Solid Tumor Oncology Division (1054)
  4. Department of Pathology and Laboratory Medicine (958)
  5. Surgery (948)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (699)
  2. Daniel Coit (543)
  3. Allan Halpern (402)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (95)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. Journal for ImmunoTherapy of Cancer (65)

More Publications

Publishers
  1. Springer (343)
  2. American Society of Clinical Oncology (285)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (163)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2776)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of absolute and relative eosinophil counts with immune-related adverse events in melanoma patients treated with ipilimumab
    Meeting Abstract

    Schindler, K.; Harmankaya, K.; Kuk, D.; Mangana, J.; Michielin, O.; Hoeller, C.; Dummer, R.; Pehamberger, H.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Meeting Abstract

    Schindler, K.; Abraham, R.; Shah, P. D.; Chandarlapaty, S.; Paik, P. K.; Bell-Mcguinn, K.; Bajorin, D. F.; Mellinghoff, I. K.; Younes, A.; Gounder, M. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Assessment of overall survival from time of metastastasis in mucosal, uveal, and cutaneous melanoma
    Meeting Abstract

    Postow, M. A.; Kuk, D.; Bogatch, K.; Carvajal, R. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Correlation of tumor-derived circulating cell free DNA (cfDNA) measured by digital PCR (DigPCR) with tumor burden measured radiographically in patients (pts) with BRAF(V600E)mutated melanoma (mel) treated with RAF inhibitor (RAFi) and/or ipilimumab (Ipi)
    Meeting Abstract

    Momtaz, P.; Gaskell, A. A.; Merghoub, T.; Viale, A.; Chapman, P. B.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Ipilimumab in acral melanoma: A retrospective review
    Meeting Abstract

    Johnson, D. B.; Peng, C.; Abramson, R. G.; Wolchok, J. D.; Sosman, J. A.; Carvajal, R. D.; Ariyan, C. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Patient-derived xenografts as models for the identification of predictive biomarkers in esophagogastric cancer
    Meeting Abstract

    Janjigian, Y. Y.; Vakiani, E.; Imtiaz, T.; Huang, X.; Ilson, D. H.; Rizk, N. P.; Coit, D. G.; Strong, V. E.; de Stanchina, E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • PD-LI expression and immune infiltrates in sarcoma
    Meeting Abstract

    D'Angelo, S. P.; Shoushtari, A. N.; Agaram, N. P.; Kuk, D.; Qin, L. X.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The neoantigen landscape underlying clinical response to ipilimumab
    Meeting Abstract

    Snyder Charen, A.; Makarov, V.; Merghoub, T.; Walsh, L.; Yuan, J.; Miller, M.; Kannan, K.; Postow, M. A.; Elipenahli, C.; Liu, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety and clinical activity of combining systemic ipilimumab with isolated limb infusion in patients with in-transit melanoma
    Meeting Abstract

    Ariyan, C. E.; Lefkowitz, R. A.; Panageas, K.; Callahan, M. K.; Misholy, O.; Bello, D.; Fisher, C.; Kotin, A.; Siegelbaum, R.; Coit, D. G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save